Due to PPARs anti-inflammatory and potentially neuroprotective effects, there is an increased interest in PPAR agonists for the treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s disease as well as ischemic brain injury, multiple sclerosis, and even addiction4, 7. This evidence concerns the gene PPARA and neurodegenerative disease.